Assignee
GENEROS BIOPHARMA LTD
CN·3 granted patents·6 pending applications·0 citations·filing 2018–2023
Top patents by PatentIndex Score
9 records- 0170US2023364072A1Compositions and methods for treating rheumatoid arthritisGENEROS BIOPHARMA LTD·Filed 2023·Application pending·0 cites
- 0265US11612595B2Compositions and methods for treating rheumatoid arthritisGENEROS BIOPHARMA LTD·Filed 2018·Granted Mar 28, 2023·0 cites·5 claims
- 0352US12409179B2Pharmaceutical combination of pimozide and methotrexate and use thereofGENEROS BIOPHARMA LTD·Filed 2020·Granted Sep 9, 2025·0 cites·16 claims
- 0448US11873321B2Compositions and methods for treating alzheimer's diseaseGENEROS BIOPHARMA LTD·Filed 2018·Granted Jan 16, 2024·0 cites·6 claims
- 0547US2023126987A1Methods for treating cytokine storm syndrome and related diseasesGENEROS BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 0647US2024391940A1Fused ring-containing compound, application thereof, and composition containing sameGENEROS BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 0744US2022204456A1Compound for treating autoimmune skin diseases caused by inflammation, and use thereofGENEROS BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 0841US2022202801A1Use of compound in preparation of drug for treating atherosclerosisGENEROS BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 0940US2023099441A1Heterocyclic compound, application thereof, and composition containing sameGENEROS BIOPHARMA LTD·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →